Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.43 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | PLAU | P00749 | 1/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2154210 | 0.86 | SMN1; SMN2 (0.49) | CYP19A1ALDH1A1SMN1; SMN2MAPTTSHR | |
| SCHEMBL28248440 | 0.82 | CYP19A1 (0.46) | CYP19A1ALDH1A1SMN1; SMN2MAPTTSHR | |
| SCHEMBL9567419 | 0.82 | CYP19A1 (0.46) | CYP19A1ALDH1A1SMN1; SMN2MAPTTSHR | |
| SCHEMBL28248935 | 0.82 | CYP19A1 (0.46) | CYP19A1ALDH1A1SMN1; SMN2MAPTTSHR | |
| SCHEMBL11337847 | 0.78 | MEN1 (0.43) | CYP19A1ALDH1A1SMN1; SMN2MAPTTSHR | |
| SCHEMBL14027044 | 0.78 | SMN1; SMN2 (0.44) | CYP19A1ALDH1A1SMN1; SMN2MAPTTSHR | |
| SCHEMBL3632404 | 0.78 | TSHR (0.46) | CYP19A1ALDH1A1SMN1; SMN2MAPTTSHR | |
| SCHEMBL5728797 | 0.78 | CYP19A1 (0.43) | CYP19A1ALDH1A1SMN1; SMN2MAPTTSHR | |
| SCHEMBL29754306 | 0.78 | MEN1 (0.43) | CYP19A1ALDH1A1SMN1; SMN2MAPTTSHR | |
| SCHEMBL30252315 | 0.78 | CYP19A1 (0.43) | CYP19A1ALDH1A1SMN1; SMN2MAPTTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7547701-B2 | Haloalkyl containing compounds as cysteine protease inhibitors | VIROBAY, INC. (US) | 2009-06-16 | — | — | US | claimed |
| US-20050182096-A1 | Haloalkyl containing compounds as cysteine protease inhibitors | AXYS PHARMACEUTICALS, INC. (US) | 2005-08-18 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050182096-A1 | Haloalkyl containing compounds as cysteine protease inhibitors | CTSF, CTSS, CTSE | CYP19A1 4617/4885FOLH1 821/4885ALDH1A1 1944/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.